Open AccessSevere edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase‐4 inhibitor
Author(s) -
Maita Hiroki,
Kobayashi Tadashi,
Akimoto Takashi,
Osawa Hiroshi,
Kato Hiroyuki
Publication year - 2022
Publication title -
journal of general and family medicine
Language(s) - English
Resource type - Journals
ISSN - 2189-7948
DOI - 10.1002/jgf2.502
Subject(s) - sitagliptin , blisters , medicine , edema , dipeptidyl peptidase 4 , dipeptidyl peptidase 4 inhibitor , adverse effect , diabetes mellitus , endocrinology , immunology , type 2 diabetes
Severe edema and blood blisters can occur as adverse events associated with sitagliptin. A history of dipeptidyl peptidase‐4 inhibitors should be considered when examining patients with edema and blood blisters of uncertain cause.